Is there a link between lung parenchyma lesions , BMI , CRP , D-dimer and acute pulmonary embolism in patients infected with COVID-19 ?
Fiche publication
Date publication
août 2021
Journal
Cardiovascular & hematological disorders drug targets
Auteurs
Membres identifiés du Cancéropôle Est :
Dr HAMMAS Karima
Tous les auteurs :
Hamadé A, Jambert L, Tousch J, Feuerstein P, Hammas K, Degoul S, Bensalah N, Michel P, Lehn-Hogg M, Obringer G, Buschenrieder N, Nusbaum P, Barakat N, Talbot M, Stephan D, Woehl B
Lien Pubmed
Résumé
Since the outbreak of the COVID-19 pandemic , increasing suggests that infected patients present a high incidence of venous thromboembolic events (VTE). The main objective of this retrospective study was to evaluate the prevalence of acute pulmonary embolism (PE) on pulmonary computer tomography angiograms (CTPA) in patients classified as COVID-19 infection. The second objective was to determine if there is a link between D-dimer levels, serum C-reactive protein (CRP ), body mass index (BMI) , the lung parenchyma lesions (LPL) and acute pulmonary embolism (PE) in these patients.
Mots clés
C- reactive protein; lung parenchyma lesions. , COVID-19; Pulmonary embolism; D-dimer; Body mass index
Référence
Cardiovasc Hematol Disord Drug Targets. 2021 Aug 11;: